Boston Scientific discontinues angiographic catheters
Boston Scientific has pulled its angiographic catheters from the market, affecting medical procedures worldwide.
Evidence dossier
Intelligence passport
Developing signal: this page remains available for transparency, but Archynetys keeps it out of search discovery until it reaches the public evidence threshold of 55.
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 3.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
Source diversity sample: simplywall.st · TCTMD.com · Cardiovascular Business · fda.gov · MedTech Dive.
How this dossier is built: methodology · AI policy · corrections.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Where it stands
Boston Scientific has discontinued its angiographic catheters. The move comes amid concerns over potential injury risks associated with the devices. The FDA issued an early alert regarding the issue, and Cardiovascular Business and MedTech Dive have confirmed the discontinuation.
The ENROUTE Transcarotid Neuroprotection System has also been recalled due to potential tip separation. The recalls and discontinutions are part of a broader pattern of high-severity device recalls by Boston Scientific. Simplywall.st has raised questions about how these recalls might reshape risk expectations for investors in BSX.
The exact nature of the injury risks and the extent of the discontinutions are not yet specified. The FDA's early alert does not detail the specific injuries reported. The impact on ongoing medical procedures and patient safety is also unclear.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
The reporting (5)
- Should Boston Scientific’s High‑Severity Device Recalls Reshape Risk Expectations for BSX Investors? simplywall.st · 2d ago
- ENROUTE Transcarotid Neuroprotection System Recalled Due to Potential for Tip Separation TCTMD.com · 2d ago
- Boston Scientific removes imaging catheters from market due to risk of injury Cardiovascular Business · 2d ago
- Early Alert: Angiographic Catheter Issue from Boston Scientific fda.gov · 2d ago
- Boston Scientific discontinues angiographic catheters MedTech Dive · 2d ago
Answered
What devices are affected by the discontinuation?
Boston Scientific has discontinued its angiographic catheters.
Why were the angiographic catheters discontinued?
The discontinuation is due to potential injury risks associated with the devices.
What other devices have been recalled by Boston Scientific?
The ENROUTE Transcarotid Neuroprotection System has also been recalled due to potential tip separation.
Topics
Related trends
Does AF Ablation Work? That’s in Question After PVI-SHAM-AF
A new sham‑controlled trial shows catheter ablation trims irregular beats but leaves patients’ quality of life untouched, challenging its perceived benefit.
Boston Scientific hit by cyberattack, global operations affected
Boston Scientific's cyberattack has halted global operations, raising concerns about medical device availability.
Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling
Boston Scientific's global operations are disrupted by a cyberattack, sending shares down
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.